Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Nov 24 | PKBO Peak Bio | Common Stock | Sale back to company | Dispose D | No | No | 0 | 37,850 | 0.00 | 0 |
14 Nov 24 | PKBO Peak Bio | Common Stock | Conversion | Acquire C | No | No | 0 | 37,850 | 0.00 | 37,850 |
14 Nov 24 | PKBO Peak Bio | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.8 | 500,000 | 400.00 k | 0 |
14 Nov 24 | PKBO Peak Bio | Warrant (Right to Purchase) Common Stock | Sale back to company | Dispose D | No | No | 0.6 | 33,340 | 20.00 k | 0 |
3 Sep 24 | PCSA Processa Pharmaceuticals | Restricted Stock Common Stock | Grant | Acquire A | No | No | 0 | 31,206 | 0.00 | 31,206 |
9 Feb 24 | PALI Palisade Bio | Common Stock, par value $0.01 | Option exercise | Acquire M | No | No | 0 | 5,820 | 0.00 | 10,920 |
9 Feb 24 | PALI Palisade Bio | Common Stock, par value $0.01 | Option exercise | Acquire M | No | No | 0 | 5,100 | 0.00 | 5,100 |
9 Feb 24 | PALI Palisade Bio | Common Stock | Option exercise | Acquire M | No | No | 0.59 | 6,880 | 4.06 k | 6,880 |
9 Feb 24 | PALI Palisade Bio | Common Stock | Option exercise | Dispose M | No | No | 0.59 | 6,880 | 4.06 k | 0 |
9 Feb 24 | PALI Palisade Bio | Common Stock | Option exercise | Acquire M | No | No | 1.6 | 12,160 | 19.46 k | 12,160 |